DEA Temporarily Bans Two Potent Synthetic Nitazenes in Schedule I
Published Date: 8/15/2025
Rule
Summary
The DEA is temporarily putting two dangerous drugs, N-pyrrolidino metonitazene and N-pyrrolidino protonitazene, into Schedule I to keep everyone safe. This means strict rules and serious penalties now apply to anyone making, selling, or using these drugs. The change kicks in right away to stop harm before it happens.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Schedule I controls and penalties applied
The DEA temporarily placed N-pyrrolidino metonitazene and N-pyrrolidino protonitazene into Schedule I. That means the strict regulatory controls and the administrative, civil, and criminal sanctions that apply to Schedule I substances now apply to anyone who manufactures, distributes, imports, exports, conducts research or instructional activities, performs chemical analysis, reverse distributes, or possesses these drugs.
Immediate action to protect public safety
The DEA says placing N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I is necessary "to avoid imminent hazard to public safety," and the temporary scheduling is effective immediately. This action is intended to prevent harms from these two benzimidazole-opioids while the scheduling is in effect.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2025-15565 — Interim Enforcement Policy for Enforcement Discretion for General Licensee Adoption of Certificate of Compliance Holder-Generated Changes
The NRC is giving general license holders a break by not punishing certain rule slip-ups when they adopt changes made by the Certificate of Compliance holder. This temporary policy helps licensees adjust without stress while keeping safety in check. It affects anyone using these licenses and could save time and money during this transition period.
Next: 2025-15609 — Endangered and Threatened Species; Designation of Critical Habitat for Five Species of Threatened Indo-Pacific Corals; Correction
The National Marine Fisheries Service fixed a small mistake in their July 2025 rule about protecting five threatened Indo-Pacific coral species. They corrected the section numbers that point to important habitat areas, making sure everything matches up perfectly. This update helps keep coral protection clear and on track, with no extra costs or delays.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in